Trials / Conditions / Antineoplastic Agents, Immunological

Antineoplastic Agents, Immunological

3 registered clinical trials studyying Antineoplastic Agents, Immunological — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients W NCT07124858	Federation Francophone de Cancerologie Digestive	N/A
Unknown	Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer NCT06134193	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2
Recruiting	Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors a NCT04572451	Yana Najjar	Phase 1